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Background
Accumulation of diffuse myocardial fibrosis / extracellular
volume (ECV) in the myocardium is common to various
cardiac diseases and is associated with an unfavorable
prognosis. Various cardiac magnetic resonance (CMR) T1
mapping techniques have recently been proposed for the
quantification of ECV, including:
1. Modified Look-Locker Inversion recovery (MOLLI)
T1 mapping including calculation of ECV, 2. Post-con-
trast multiple-breath-hold T1 mapping. 3. Native (pre-
contrast) T1 mapping.
T1 mapping is a promising technique, however, vali-
dation data based on myocardial biopsy are sparse.
Methods
36 heart failure patients underwent CMR T1 mapping
and left-ventricular biopsy within 4 weeks. CMR proto-
cols (1.5-T scanner, (Magnetom Avanto, Siemens
Healthcare, Erlangen, Germany) included non-product
MOLLI and multiple-breath-hold T1 mapping.
The population consisted of 22 patients with HFpEF
(heart failure with preserved ejection fraction), 7 with
cardiac amyloidosis, 3 with HFrEF (heart failure with
reduced ejection fraction) and 4 with organic mitral
regurgitation (MR).
Specimens were stained using modified Trichrome.
TissueFAXS and dedicated software were used to quan-
tify ECV.
Results
ECV by TissueFAXS was 32±17% and 35±13% by CMR
MOLLI. Post-contrast T1 times by the multiple-breath-
hold sequence were 411±79ms, native T1 times were
1009±73ms. Patients with amyloidosis had significantly
more ECV by TissueFAXS (59±13%, p<0.001) and with
CMR MOLLI (56±12%, p<0.001) compared with the
other pathologies.
The amount of TissueFAXS ECV correlated signifi-
cantly with native T1 times (r=0.657, p<0.001), MOLLI
ECV (r=0.907, p<0.001) and with multiple-breath-hold
post-contrast T1 times (r=-0.683, p<0.001). When
excluding patients with amyloidosis, only MOLLI ECV
significantly correlated with histology (r=0.491,
p=0.015), whereas multiple-breath-hold post-contrast T1
times just missed the level of significance (r=-0.413,
p=0.056).
Conclusions
In our series, MOLLI ECV appears to be the most pro-
mising method for the quantification of extracellular
matrix when validated against histology. Future studies
need to define the prognostic value of T1 mapping in a
large prospective cohort.
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